Skip to main content

Dana-Farber/Harvard Cancer Center

Dana-Farber/Harvard Cancer Center (DF/HCC) is a collaboration between academic institutions, world-renowned for its leadership in adult and pediatric cancer treatment and research. Dana-Farber Cancer Institute is a founding member of DF/HCC, established in Boston in 1947 under the leadership of Dr. Sidney Farber, the father of modern chemotherapy, and one of the first to become an NCI-Designated Comprehensive Cancer Center in 1973.

Focused equally on cancer research and care, DF/HCC’s mission is to provide expert, compassionate care to children and adults with cancer, while advancing the understanding, diagnosis, treatment, cure, and prevention of cancer and related diseases, and training the next generation of clinical and scientific leaders.

In addition to Dana-Farber Cancer Institute, the DF/HCC consortium includes six other Harvard-affiliated institutions, including Beth Israel Deaconess Medical Center, Boston Children’s Hospital, Brigham and Women’s Hospital, Harvard Medical School, Harvard T.H. Chan School of Public Health, and Massachusetts General Hospital. The member institutions combine their scientific strengths to accelerate research findings from the laboratory, clinical research trials, and studies of populations, enhancing patient care and the understanding of underlying causes of cancer.

Read more about the Dana-Farber/Harvard Cancer Center.

Dana-Farber Cancer Institute

Comp
Benjamin L Ebert, MD, PhD
President & CEO
450 Brookline Avenue
Mailstop: BP332A
Boston, MA 02115
(617) 632-2100
Admin Leader
Deborah Goff, PhD
Deputy Associate Director
COE Leader
Vish Viswanath, PhD, MPH
Associate Director, Community Outreach and Engagement
CRTEC Leader
Lee Nadler, MD
Associate Director, Cancer Research Training and Education
PED Leader
Ramesh  Shivdasani, MD, PhD
Cancer Center Deputy Director; Acting AD for PED/DE

Research Programs

Research Program Program Leaders
Breast Cancer Program Leif Ellisen, MD, PhD; Elizabeth Mittendorf, MD, PhD; Sara Tolaney, MD, MPH
Cancer Care Delivery Research Program Nancy Keating, MD, MPH; Jennifer Temel, MD; Jennifer Mack, MD, MPH
Cancer Cell Biology Program Jeffrey Harper, PhD; Kornelia Polyak, MD, PhD; Raul Mostoslavsky, MD, PhD
Cancer Data Sciences Program Martin Aryee, PhD; Xihong Lin, PhD; Franziska Michor, PhD
Cancer Epidemiology Program Andrew Chan, MD, MPH; Brittany Charlton, ScD, MSc; Heather Eliassen, ScD
Cancer Genetics and Epigenetics Program Gad Getz, MSc, PhD; Cigall Kadoch, PhD; Eliezer Van Allen, MD
Cancer Immunology Program Arlene Sharpe, MD, PhD; Kai Wucherpfennig, MD, PhD
Cancer Risk, Prevention and Early Detection Program Lecia Sequist, MD, MPH; Sapna Syngal, MD, MPH; Guillermo Tearney, MD, PhD
Developmental Therapeutics Program Keith Flaherty, MD; Geoffrey Shapiro, MD, PhD
Gastrointestinal Malignancies Program Ryan Corcoran, MD, PhD; Brian Wolpin, MD, PhD
Gynecologic Cancers Program Cesar Castro, MD, MMsc; Alan D'Andrea, MD; Ursula Matulonis, MD
Kidney Cancer Program David McDermott, MD; Toni Choueiri, MD; Sabina Signoretti, MD
Leukemia Program Timothy Graubert, MD; Andrew Lane, MD, PhD; Jacalyn Rosenblatt, MD
Lung Cancer Program Justin Gainor, MD; Bruce Johnson, MD; Carla Kim, PhD
Lymphoma and Myeloma Program Matthew Davids, MD, MMsc; Irene Ghobrial, MD
Melanoma Program David Fisher, MD, PhD; Frank Hodi, MD
Neuro-Oncology Program Tracy Batchelor, MD, MPH; Daphne Haas-Kogan, MD; Scott Plotkin, MD, PhD; Mario Suva, MD, PhD
Prostate Cancer Program Steven Balk, MD, PhD; Matthew Smith, MD, PhD; Mary-Ellen Taplin, MD

Shared Resources

Category Resource Directors
Cat 1: Laboratory Science Cancer Proteomics Core Towia Libermann, PhD
Cat 1: Laboratory Science Mouse Engineering Core Arlene Sharpe, MD, PhD
Cat 3: Epidemiology, Cancer Control Health Communication Core Vish Viswanath, PhD
Cat 3: Epidemiology, Cancer Control Survey and Qualitative Methods Core Wendy London, PhD
Cat 4: Clinical Research Cell Manipulation Core Jerome Ritz, MD
Cat 4: Clinical Research Research Pharmacy Core Sylvia Bartel, RPh, MPH
Cat 4: Clinical Research Rodent Histopathology Core Peter Howley, MD
Cat 4: Clinical Research Specialized Histopathology Services Core Jon Aster, MD, PhD; Anat Stemmer-Rachamimov, MD
Cat 4: Clinical Research Tissue Microarray and Imaging Core Sabina Signoretti, MD
Cat 4: Clinical Research Tumor Imaging Metrics Core Gordon Harris, PhD; Annick Van Den Abbeele, MD
Cat 6: Biostatistics Biostatistics Core Paul Catalano, ScD; Rebecca Gelman, PhD
Cat 7: Informatics Bioinformatics Training Core Shannan Ho Sui, PhD
Last Updated
November 19, 2024